Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-6405
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda ; volume:18 ; number:1 ; day:20 ; month:3 ; year:2021 ; pages:1-9 ; date:12.2021
AIDS research and therapy ; 18, Heft 1 (20.3.2021), 1-9, 12.2021
- Urheber
-
Nuwagira, Edwin
Lumori, Boniface A. E.
Muhindo, Rose
Kanyesigye, Michael
Amir, Abdallah
Muyindike, Winnie
Muzoora, Conrad
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12981-021-00331-5
- URN
-
urn:nbn:de:101:1-2021050614545877517857
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nuwagira, Edwin
- Lumori, Boniface A. E.
- Muhindo, Rose
- Kanyesigye, Michael
- Amir, Abdallah
- Muyindike, Winnie
- Muzoora, Conrad
- SpringerLink (Online service)
Ähnliche Objekte (12)
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India
Immune reconstitution inflammatory syndrome (IRIS) in HIV positive patients initiated on antiretroviral therapy (ART)
Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa
Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India
Immune reconstitution inflammatory syndrome (IRIS) in HIV positive patients initiated on antiretroviral therapy (ART)
Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa
Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India
Immune reconstitution inflammatory syndrome (IRIS) in HIV positive patients initiated on antiretroviral therapy (ART)
Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa